Office Safety Measures

Like you, we are eager and hopeful that the worst of the Coronavirus (COVID-19) will soon be in our rearview mirror. As we collectively start to emerge from this life altering period and work toward returning to a state of normalcy or defining what our new normal will be, it is our goal to continue our mission of making the health and safety of our patients and staff our top priority through every step we implement.

We are instituting a phased reopening plan for our office beginning May 4, 2020. This will allow us to start to resume the care and procedures that have been postponed through this time period. We value your continued trust in us as your eye care provider. In order to maintain the highest levels of health and safety through our phased reopening plan, we will be adhering to the following:

With these safety measures in place, we hope you will feel comfortable scheduling your appointment with us for your essential eye care. If you aren’t ready to make your in-office appointment yet, we will be here for you when you are ready. Routine and ongoing eye exams are essential to staying on top of your eye health and ahead of any undetected conditions and/or unmanaged chronic diseases.

We will continue to keep you updated as we work through the phases of our reopening plan. We are starting things slowly and will evolve our phases as we gain more insight about what processes are most effective and we all have a better understanding of how to move beyond COVID-19.

Call us today at 410-377-2044 to request your appointment. If you had an appointment or surgery that was previously canceled, we will be reaching out to you to schedule your new appointment or surgery if we have not done so already. Please note that the earliest we will schedule any elective surgeries is Tuesday, May 26th, and we will be scheduling patients whose appointments had previously been canceled first.

We look forward to safely seeing you again!

 

Click here to view our previous updates related to Coronavirus (COVID-19)